
What happened
In fiscal 2026, Aehr posted $50.0 million revenue (down 15.2%), a $7.1 million net loss, and negative $5.4 million free cash flow, while KLA reported $13.6 billion revenue (up 11.7%), $4.8 billion net income, and $3.8 billion free cash flow.
Why it matters
KLA's profitability and dividend make it the more stable option for AI exposure, whereas Aehr's losses and cash burn signal higher risk for investors.
What to watch
Aehr's high stock valuation suggests future growth is already priced in, limiting upside, and its customer concentration remains a key risk. Watch whether Aehr's record bookings of $60.7 million convert into profitable revenue.
WHO IT HITSThis comparison directly informs retail investors and portfolio managers deciding how to allocate AI exposure, particularly those weighing small-cap growth against mega-cap stability in semiconductor equipment.
Summaries like this, in your inbox every morning.
The comparison comes as investors look for ways to gain exposure to artificial intelligence beyond the headline chipmakers. Aehr Test Systems serves the high-growth silicon carbide market for electric vehicles and high-bandwidth memory for AI infrastructure, but its fiscal 2026 results show the risks of that niche: revenue fell 15.2% to $50.0 million, and the company swung to a $7.1 million net loss. Its five largest customers accounted for nearly 70% of net sales, exposing it to the capital spending cycles of a handful of buyers.
KLA, by contrast, provides process control tools across the entire chip-making industry. Its scale showed in fiscal 2026, with revenue up 11.7% to $13.6 billion and net income of $4.8 billion. Its services business, about 23% of revenue, adds a recurring stream. KLA is not without concentration risk, as Taiwan Semiconductor Manufacturing Company accounts for more than 10% of revenues, and it faces competition from Applied Materials and Lasertec.
The valuation gap is stark: Aehr trades at a much higher multiple despite its net loss, while KLA's forward P/E is 33.1x. The Motley Fool's pick hinges on whether Aehr's record bookings of $60.7 million and fourth-quarter sales of $18.8 million can translate into sustained profitability, or whether KLA's steady profit and dividend will continue to look safer for AI exposure.
For example, today's edition would include:
AI-summarized, only the topics you pick — one digest a day via Email, Slack, or Discord.
Free · 30 seconds with Google · unsubscribe anytimeWhat is AIToday? →
Ask AI anything about this article. Q&As are published on this page for other readers too.
Twist Bioscience agreed to supply antibody characterization data services to Eli Lilly's AI-driven TuneLab dru…

Citi forecasts HBM bit demand rising 62% to 75.2 billion gigabits in 2027 and another 69% to 127.0 billion gig…

Lam Research posted record fiscal 2026 results with higher margin targets and richer dividends

RTX says AI-enabled borescoping has cut overall engine inspection time by more than 30%, with report generatio…

Yahoo Finance compared Nvidia and Micron and picked Micron as the better AI stock for 2027, citing Micron's ma…

Berenberg lifted its Lam Research price target to $420, flagging wafer fab equipment spending rising toward $1…
